Come up with a name for your new list and we'll add to it:
Siamab Therapeutics raised a round of funding on April 09, 2015. Investors include
Boston Harbor Angels.
Siamab Therapeutics, formerly Sialix, is a biopharmaceutical company developing novel cancer immunotherapies. Siamab has developed a platform of technologies that enable the rapid discovery and develo…